This page shows the result of browsing biomarker from different fieldss.For more information see HELP page.
The total number entries retrieved from this search are 452Biomarker ID | Biomarker | Biomolecule | Subject | Regulation | Biomarker's type | Experiment | Level of significance | Source | PMID |
---|---|---|---|---|---|---|---|---|---|
2339 | SGK | RNAs | Human | Downregulated in HCCs with PVI in comparison with HCCs without PVI (with Fisher ratio 1.64) | Prognostic | HCC with PVI v/s HCC without PVI | p < 0.05 | Tissue | 17088983 |
2340 | GPRK6 | RNAs | Human | Downregulated in HCCs with PVI in comparison with HCCs without PVI (with Fisher ratio 1.59) | Prognostic | HCC with PVI v/s HCC without PVI | p < 0.05 | Tissue | 17088983 |
2341 | ZNF216 | RNAs | Human | Downregulated in HCCs with PVI in comparison with HCCs without PVI (with Fisher ratio 1.54) | Prognostic | HCC with PVI v/s HCC without PVI | p < 0.05 | Tissue | 17088983 |
2342 | TIAL1 | RNAs | Human | Downregulated in HCCs with PVI in comparison with HCCs without PVI (with Fisher ratio 1.53) | Prognostic | HCC with PVI v/s HCC without PVI | p < 0.05 | Tissue | 17088983 |
2343 | KIAA0564 | RNAs | Human | Downregulated in HCCs with PVI in comparison with HCCs without PVI (with Fisher ratio 1.48) | Prognostic | HCC with PVI v/s HCC without PVI | p < 0.05 | Tissue | 17088983 |
2344 | GADD45B | RNAs | Human | Downregulated in HCCs with PVI in comparison with HCCs without PVI (with Fisher ratio 1.41) | Prognostic | HCC with PVI v/s HCC without PVI | p < 0.05 | Tissue | 17088983 |
2345 | TAPBP | RNAs | Human | Downregulated in HCCs with PVI in comparison with HCCs without PVI (with Fisher ratio 1.35) | Prognostic | HCC with PVI v/s HCC without PVI | p < 0.05 | Tissue | 17088983 |
2346 | RHO6 | RNAs | Human | Downregulated in HCCs with PVI in comparison with HCCs without PVI (with Fisher ratio 1.25) | Prognostic | HCC with PVI v/s HCC without PVI | p < 0.05 | Tissue | 17088983 |
2347 | SLC9A3R2 | RNAs | Human | Downregulated in HCCs with PVI in comparison with HCCs without PVI (with Fisher ratio 1.23) | Prognostic | HCC with PVI v/s HCC without PVI | p < 0.05 | Tissue | 17088983 |
2348 | HFL1 | RNAs | Human | Downregulated in HCCs with PVI in comparison with HCCs without PVI (with Fisher ratio 1.23) | Prognostic | HCC with PVI v/s HCC without PVI | p < 0.05 | Tissue | 17088983 |
2349 | CG018 | RNAs | Human | Downregulated in HCCs with PVI in comparison with HCCs without PVI (with Fisher ratio 1.23) | Prognostic | HCC with PVI v/s HCC without PVI | p < 0.05 | Tissue | 17088983 |
2350 | PIK3R1 | RNAs | Human | Downregulated in HCCs with PVI in comparison with HCCs without PVI (with Fisher ratio 1.22) | Prognostic | HCC with PVI v/s HCC without PVI | p < 0.05 | Tissue | 17088983 |
2351 | CYP3A5P2 | RNAs | Human | Downregulated in HCCs with PVI in comparison with HCCs without PVI (with Fisher ratio 1.21) | Prognostic | HCC with PVI v/s HCC without PVI | p < 0.05 | Tissue | 17088983 |
2352 | LAMP2 | RNAs | Human | Downregulated in HCCs with PVI in comparison with HCCs without PVI (with Fisher ratio 1.20) | Prognostic | HCC with PVI v/s HCC without PVI | p < 0.05 | Tissue | 17088983 |
2353 | AQP3 | RNAs | Human | Downregulated in HCCs with PVI in comparison with HCCs without PVI (with Fisher ratio 1.19) | Prognostic | HCC with PVI v/s HCC without PVI | p < 0.05 | Tissue | 17088983 |
2354 | SEMA6C | RNAs | Human | Downregulated in HCCs with PVI in comparison with HCCs without PVI (with Fisher ratio 1.19) | Prognostic | HCC with PVI v/s HCC without PVI | p < 0.05 | Tissue | 17088983 |
2355 | SAT | RNAs | Human | Downregulated in HCCs with PVI in comparison with HCCs without PVI (with Fisher ratio 1.18) | Prognostic | HCC with PVI v/s HCC without PVI | p < 0.05 | Tissue | 17088983 |
2356 | PTPRD | RNAs | Human | Downregulated in HCCs with PVI in comparison with HCCs without PVI (with Fisher ratio 1.15) | Prognostic | HCC with PVI v/s HCC without PVI | p < 0.05 | Tissue | 17088983 |
2357 | MASP2 | RNAs | Human | Downregulated in HCCs with PVI in comparison with HCCs without PVI (with Fisher ratio 1.15) | Prognostic | HCC with PVI v/s HCC without PVI | p < 0.05 | Tissue | 17088983 |
2358 | GADD45B | RNAs | Human | Downregulated in HCCs with PVI in comparison with HCCs without PVI (with Fisher ratio 1.14) | Prognostic | HCC with PVI v/s HCC without PVI | p < 0.05 | Tissue | 17088983 |
2359 | RhoC | Protein and RNA | Human | Upregulated in highly invasive NHCC than in less invasive SLHCC and upregulated in EHML (Extrahepatic Metastatic Lesions) than HCC and PCLT (Pericarcinomatous liver tissues). | Prognostic | EHML (Extrahepatic Metastatic Lesions) v/s HCC and PCLT(pericarcinomatous liver tissues); increased RhoC expression strongly correlates with vein invasion | p < 0.01 | Tissue | 15150600 |
2360 | PARD3, INSIG1, MPHOSPH9, SKP2, CUL4B, CETN2, ETS2, USH1C, PTPN11, OASL, ARL5, SMURF2, CDC42SE1, CSNK1G3, RACGAP1, DNAJC10, KCNK1, CDO1, CNGA1, NUDT9, GSTM3, SLC16A5, SARA2, ID2, MTHFD2L, SYNGR2, PRL10A, RNF130, MAFB, FLJ23749, LARP6, R3HDM, ZNF652, PGGT1B, HEXB, SLC27A2, ZBTB38, SH3GLB2, AGPAT3, GCH | RNAs | Human | Differentially expressed between recurrence HCC disease | Prognostic | Recurrent v/s non-recurrent HCC | p < 0.05 | Tissue | 17975138 |
2365 | PFKFB1 | RNAs | Human | Upregulated in HCC than non-tumor | Diagnostic | HCC v/s non-tumor | p < 0.05 | Tissue | 11752456 |
2366 | G6PC | RNAs | Human | Downregulated in HCC than non-tumor | Diagnostic | HCC v/s non-tumor | p < 0.05 | Tissue | 11752456 |
2367 | PCK1 | RNAs | Human | Downregulated in HCC than non-tumor | Diagnostic | HCC v/s non-tumor | p < 0.05 | Tissue | 11752456 |
2368 | Fructose-1,6-biphosphatase | RNAs | Human | Downregulated in HCC than non-tumor | Diagnostic | HCC v/s non-tumor | p < 0.05 | Tissue | 11752456 |
2369 | NADH dehydrogenase Fe-S protein 8 | RNAs | Human | Downregulated in HCC than non-tumor | Diagnostic | HCC v/s non-tumor | p < 0.05 | Tissue | 11752456 |
2370 | NADH dehydrogenase 1-alpha subcomplex | RNAs | Human | Downregulated in HCC than non-tumor | Diagnostic | HCC v/s non-tumor | p < 0.05 | Tissue | 11752456 |
2371 | NADH dehydrogenase Fe-S protein 6 | RNAs | Human | Downregulated in HCC than non-tumor | Diagnostic | HCC v/s non-tumor | p < 0.05 | Tissue | 11752456 |
2372 | PDHA1/A2/B | RNAs | Human | Downregulated in HCC than non-tumor | Diagnostic | HCC v/s non-tumor | p < 0.05 | Tissue | 11752456 |
2373 | GALK1 | RNAs | Human | Downregulated in HCC than non-tumor | Diagnostic | HCC v/s non-tumor | p < 0.05 | Tissue | 11752456 |
2374 | GALK2 | RNAs | Human | Downregulated in HCC than non-tumor | Diagnostic | HCC v/s non-tumor | p < 0.05 | Tissue | 11752456 |
2375 | ALDOB | RNAs | Human | Downregulated in HCC than non-tumor | Diagnostic | HCC v/s non-tumor | p < 0.05 | Tissue | 11752456 |
2376 | UGP2 | RNAs | Human | Downregulated in HCC than non-tumor | Diagnostic | HCC v/s non-tumor | p < 0.05 | Tissue | 11752456 |
2377 | GYS2 | RNAs | Human | Downregulated in HCC than non-tumor | Diagnostic | HCC v/s non-tumor | p < 0.05 | Tissue | 11752456 |
2378 | LAP3 | RNAs | Human | Upregulated in HCC than non-tumor | Diagnostic | HCC v/s non-tumor | p < 0.05 | Tissue | 11752456 |
2379 | Alanine:glyoxylate aminotransferase | RNAs | Human | Upregulated in HCC than non-tumor | Diagnostic | HCC v/s non-tumor | p < 0.05 | Tissue | 11752456 |
2380 | Carbamyl phosphate synthetase I | RNAs | Human | Downregulated in HCC than non-tumor | Diagnostic | HCC v/s non-tumor | p < 0.05 | Tissue | 11752456 |
2381 | Phenylalanine hydroxylase | RNAs | Human | Downregulated in HCC than non-tumor | Diagnostic | HCC v/s non-tumor | p < 0.05 | Tissue | 11752456 |
2382 | Kynurenine 3-hydroxylase | RNAs | Human | Downregulated in HCC than non-tumor | Diagnostic | HCC v/s non-tumor | p < 0.05 | Tissue | 11752456 |
2383 | Ornithine decarboxylase | RNAs | Human | Downregulated in HCC than non-tumor | Diagnostic | HCC v/s non-tumor | p < 0.05 | Tissue | 11752456 |
2384 | Prealbumin | RNAs | Human | Downregulated in HCC than non-tumor | Diagnostic | HCC v/s non-tumor | p < 0.05 | Tissue | 11752456 |
2385 | Serum albumin | RNAs | Human | Downregulated in HCC than non-tumor | Diagnostic | HCC v/s non-tumor | p < 0.05 | Tissue | 11752456 |
2386 | Transferrin | RNAs | Human | Downregulated in HCC than non-tumor | Diagnostic | HCC v/s non-tumor | p < 0.05 | Tissue | 11752456 |
2387 | FGA | RNAs | Human | Downregulated in HCC than non-tumor | Diagnostic | HCC v/s non-tumor | p < 0.05 | Tissue | 11752456 |
2388 | FGB | RNAs | Human | Downregulated in HCC than non-tumor | Diagnostic | HCC v/s non-tumor | p < 0.05 | Tissue | 11752456 |
2389 | Alpha-1 type XVI collagen | RNAs | Human | Downregulated in HCC than non-tumor | Diagnostic | HCC v/s non-tumor | p < 0.05 | Tissue | 11752456 |
2390 | Alpha-1 type XVI collagen | RNAs | Human | Downregulated in HCC than non-tumor | Diagnostic | HCC v/s non-tumor | p < 0.05 | Tissue | 11752456 |
2391 | Antithrombin III | RNAs | Human | Downregulated in HCC than non-tumor | Diagnostic | HCC v/s non-tumor | p < 0.05 | Tissue | 11752456 |
2392 | Coagulation factor XIII | RNAs | Human | Downregulated in HCC than non-tumor | Diagnostic | HCC v/s non-tumor | p < 0.05 | Tissue | 11752456 |